[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $elut Elutia sells BioEnvelope business to Boston Scientific for $88M. The company is refocusing on breast reconstruction and drug-eluting technologies, with positive sentiment surrounding the deal, but declining engagements are a concern. ### About $elut Elutia ($ELUT) is a company in the biotech or medical device sector. ### Insights [#](/topic/$elut/insights) - $elut posts created is up XXX% from the previous week. ### Engagements: XX [#](/topic/$elut/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$elut/time-series/interactions.tsv) **Current Value**: XX **Daily Average**: XXXXX **1 Week**: XXX -XX% **1 Month**: XXXXX -XX% **1-Year High**: XXXXXX on 2025-08-14 **1-Year Low**: X on 2025-06-04 | Social Network | X | | -------------- | - | | Engagements | XX | ### Mentions: X [#](/topic/$elut/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$elut/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: XX **1 Month**: XX +107% **1-Year High**: XXX on 2025-07-03 **1-Year Low**: X on 2025-04-27 | Social Network | X | | -------------- | - | | Mentions | XX | ### Creators: X [#](/topic/$elut/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$elut/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $elut in the last XX hours which is up XX% from X in the previous XX hours **Daily Average**: XX **1 Month**: XX +79% **1-Year High**: XXX on 2025-07-03 **1-Year Low**: X on 2025-04-27 The most influential creators that mention $elut in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | X | XXXXX | X | X | [View More](/list/creators/$elut/100) ### Sentiment: XXX% [#](/topic/$elut/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$elut/time-series/sentiment.tsv) **Current Value**: XXX% **Daily Average**: XX% **1 Week**: XXX% no change **1 Month**: XXX% no change **1-Year High**: XXX% on 2025-06-26 **1-Year Low**: XX% on 2025-08-25 **Most Supportive Themes** - **BioEnvelope Business Sale:** (60%) Elutia's sale of its BioEnvelope business to Boston Scientific for $XX million is a key positive development. - **Focus on Breast Reconstruction:** (20%) The deal allows Elutia to focus on breast reconstruction and drug-eluting pipelines. **Most Critical Themes** - **General Market Sentiment:** (10%) While sentiment is currently positive, the lack of specific details on future product performance could be a concern. - **Engagement Decline:** (10%) Despite positive news, the decline in engagements and mentions could indicate a lack of sustained interest. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | X | XX% | XX | XX% | X | X% | | | | | | | | | | Total | X | XX% | XX | XX% | X | X% | **Top assets mentioned** In the posts about $elut in the last XX hours [Boston Scientific Corporation (BSX)](/topic/boston-scientific) [ACV Auctions Inc. Class A Common Stock (ACVA)](/topic/$acva) [Alight, Inc. (ALIT)](/topic/$alit) [Tourmaline Bio, Inc. Common Stock (TRML)](/topic/$trml) [Canadian National Railway (CNI)](/topic/$cni) [Cantina Royale (CRT)](/topic/$crt) [Alcon Inc. Ordinary Shares (ALC)](/topic/$alc) [Amcor PLC (AMCR)](/topic/amcor-plc) [ASGN Incorporated (ASGN)](/topic/$asgn) **Top topics mentioned** In the posts about $elut in the last XX hours [boston scientific](/topic/boston-scientific), [stocks healthcare](/topic/stocks-healthcare), [boston](/topic/boston), [$88m](/topic/$88m), [$acva](/topic/$acva), [$alit](/topic/$alit), [ticker](/topic/ticker), [$trml](/topic/$trml), [momentum](/topic/momentum), [nasdaq](/topic/nasdaq), [investment](/topic/investment), [$oprt](/topic/$oprt), [debt](/topic/debt), [$apvo](/topic/$apvo), [$cni](/topic/$cni), [$crt](/topic/$crt), [$aact](/topic/$aact), [$alc](/topic/$alc), [amcor plc](/topic/amcor-plc), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$adtx](/topic/$adtx), [$aixi](/topic/$aixi), [$amwl](/topic/$amwl), [$asgn](/topic/$asgn) ### Top Social Posts [#](/topic/$elut/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "7/ 👀 $ELUT $88M Boston Sci sale adds cash buffer; insider buys at $XXXX ahead of catalysts. $OPRT Third straight GAAP profit & debt paydown mark a real turnaround story. $HBNC Regional bank with insider accumulation ahead of Oct. XX earnings" [X Link](https://x.com/Analytica_X/status/1978422006535331878) [@Analytica_X](/creator/x/Analytica_X) 2025-10-15T11:25Z 1023 followers, XXX engagements "$ELUT Up XX% AH 🚀🔥 🔹 Closed $88M BioEnvelope sale to Boston Scientific major cash boost 💰 🔹 Refocusing on NXT-41x drug-eluting biomatrix for breast reconstruction 🧬 🔹 EluPro sales surged XX% QoQ margins climbing 📈 🔹 Analysts see big upside with PTs up to $XX 📊 Eyes on $ELUT medtech turnaround gaining traction 👀 #ELUT #Biotech #Momentum Not financial advice. For informational purposes only" [X Link](https://x.com/Bezel4455/status/1975668307060457911) [@Bezel4455](/creator/x/Bezel4455) 2025-10-07T21:03Z 3981 followers, XXX engagements "Elutia BioEnvelope Boston Scientific Corporation XX $ELUT" [X Link](https://x.com/4444m6666/status/1973382929448337455) [@4444m6666](/creator/x/4444m6666) 2025-10-01T13:42Z XXX followers, XXX engagements "Elutia Sells BioEnvelope Business to Boston Scientific for $88M 💰💉 Date: October X 2025 Company: Elutia Inc. (NASDAQ: $ELUT $BSX) Elutia has successfully closed the sale of its BioEnvelope business including the EluPro and CanGaroo bioenvelopes to Boston Scientific for $XX million in cash. 🎉 This strategic move allows Elutia to focus on the advancement of its NXT-41x biomatrix platform aimed at tackling post-mastectomy reconstruction infections. NXT-41x will support tissue regeneration and provide extended antibiotic protection for patients. 💡 Key Points: BioEnvelope sale strengthens" [X Link](https://x.com/FoxRunnerAlerts/status/1973368280069886247) [@FoxRunnerAlerts](/creator/x/FoxRunnerAlerts) 2025-10-01T12:43Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Elutia sells BioEnvelope business to Boston Scientific for $88M. The company is refocusing on breast reconstruction and drug-eluting technologies, with positive sentiment surrounding the deal, but declining engagements are a concern.
Elutia ($ELUT) is a company in the biotech or medical device sector.
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXXXX
1 Week: XXX -XX%
1 Month: XXXXX -XX%
1-Year High: XXXXXX on 2025-08-14
1-Year Low: X on 2025-06-04
Social Network | X |
---|---|
Engagements | XX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
1 Month: XX +107%
1-Year High: XXX on 2025-07-03
1-Year Low: X on 2025-04-27
Social Network | X |
---|---|
Mentions | XX |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $elut in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: XX
1 Month: XX +79%
1-Year High: XXX on 2025-07-03
1-Year Low: X on 2025-04-27
The most influential creators that mention $elut in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@MarcJacksonLA | X | XXXXX | X | X |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% no change
1-Year High: XXX% on 2025-06-26
1-Year Low: XX% on 2025-08-25
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | X | XX% | XX | XX% | X | X% |
Total | X | XX% | XX | XX% | X | X% |
Top assets mentioned In the posts about $elut in the last XX hours
Boston Scientific Corporation (BSX) ACV Auctions Inc. Class A Common Stock (ACVA) Alight, Inc. (ALIT) Tourmaline Bio, Inc. Common Stock (TRML) Canadian National Railway (CNI) Cantina Royale (CRT) Alcon Inc. Ordinary Shares (ALC) Amcor PLC (AMCR) ASGN Incorporated (ASGN)
Top topics mentioned In the posts about $elut in the last XX hours
boston scientific, stocks healthcare, boston, $88m, $acva, $alit, ticker, $trml, momentum, nasdaq, investment, $oprt, debt, $apvo, $cni, $crt, $aact, $alc, amcor plc, stocks consumer cyclical, $adtx, $aixi, $amwl, $asgn
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"7/ 👀 $ELUT $88M Boston Sci sale adds cash buffer; insider buys at $XXXX ahead of catalysts. $OPRT Third straight GAAP profit & debt paydown mark a real turnaround story. $HBNC Regional bank with insider accumulation ahead of Oct. XX earnings"
X Link @Analytica_X 2025-10-15T11:25Z 1023 followers, XXX engagements
"$ELUT Up XX% AH 🚀🔥 🔹 Closed $88M BioEnvelope sale to Boston Scientific major cash boost 💰 🔹 Refocusing on NXT-41x drug-eluting biomatrix for breast reconstruction 🧬 🔹 EluPro sales surged XX% QoQ margins climbing 📈 🔹 Analysts see big upside with PTs up to $XX 📊 Eyes on $ELUT medtech turnaround gaining traction 👀 #ELUT #Biotech #Momentum Not financial advice. For informational purposes only"
X Link @Bezel4455 2025-10-07T21:03Z 3981 followers, XXX engagements
"Elutia BioEnvelope Boston Scientific Corporation XX $ELUT"
X Link @4444m6666 2025-10-01T13:42Z XXX followers, XXX engagements
"Elutia Sells BioEnvelope Business to Boston Scientific for $88M 💰💉 Date: October X 2025 Company: Elutia Inc. (NASDAQ: $ELUT $BSX) Elutia has successfully closed the sale of its BioEnvelope business including the EluPro and CanGaroo bioenvelopes to Boston Scientific for $XX million in cash. 🎉 This strategic move allows Elutia to focus on the advancement of its NXT-41x biomatrix platform aimed at tackling post-mastectomy reconstruction infections. NXT-41x will support tissue regeneration and provide extended antibiotic protection for patients. 💡 Key Points: BioEnvelope sale strengthens"
X Link @FoxRunnerAlerts 2025-10-01T12:43Z XXX followers, XXX engagements
/topic/$elut